Overview
For sponsors with rare-disease assets, orphan indications or small portfolios, regulatory and clinical strategy need to inform each other in real time. A trial design decision affects a submission. A submission decision affects the trial.
PharmaKnowl runs clinical research and regulatory work inside the same team, with the same accountability, on the same timeline. We work on expedited SFDA pathways, including Orphan Drug Designation, Priority Review and Compassionate Use, and we can position them while a product is still in Phase 3 development.






